New hope for HS sufferers: experimental drug BFB759 enters Late-Stage trial

NCT ID NCT07287644

Recruiting now Disease control Sponsor: Bluefin Biomedicine, Inc. Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 19 times

Summary

This study tests a new drug called BFB759 in 210 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. Participants receive either BFB759 or a placebo for up to 40 weeks to see if the drug reduces abscesses and inflammatory bumps. The goal is to control the disease, not cure it, and participants must avoid certain other medications during the trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Apex Clinical Research Center, LLC
RECRUITING

Canton, Ohio, 44718, United States
Apex Clinical Research Center, LLC
RECRUITING

Mayfield Heights, Ohio, 44124, United States
Center for Skin Science and Innovation
RECRUITING

Fort Lauderdale, Florida, 33308, United States
Clinical Science Institute
RECRUITING

Santa Monica, California, 90404, United States
Clinical Trials Management, LLC
RECRUITING

Tampa, Florida, 33607, United States
Clinical Trials Management, LLC
RECRUITING

Metairie, Louisiana, 70006, United States
DS Research of Kentucky
RECRUITING

Louisville, Kentucky, 40241, United States
DelRicht Research
RECRUITING

Atlanta, Georgia, 30329, United States
DelRicht Research
RECRUITING

New Orleans, Louisiana, 70115, United States
DelRicht Research
RECRUITING

Wildwood, Missouri, 63040, United States
DelRicht Research
RECRUITING

Mt. Pleasant, South Carolina, 29464, United States
DelRicht Research
RECRUITING

Smyrna, Tennessee, 37167, United States
DelRicht Research
RECRUITING

Prosper, Texas, 75078, United States
Dermatology Specialists of Spokane
RECRUITING

Spokane, Washington, 99202, United States
Encino Research Center
RECRUITING

Encino, California, 91436, United States
Equity Medical LLC
RECRUITING

The Bronx, New York, 10455, United States
JDR Dermatology Research LLC
RECRUITING

Las Vegas, Nevada, 89145, United States
MI Skin Innovations
RECRUITING

Northville, Michigan, 48167, United States
Martha Stewart
RECRUITING

Mandeville, Louisiana, 70448, United States
Medical Univ of SC Department of Dermatology
RECRUITING

Charleston, South Carolina, 29425, United States
North York Research Inc.
RECRUITING

Toronto, Ontario, M2N 3A6, Canada
Oakland Hills Dermatology
RECRUITING

Auburn Hills, Michigan, 48326, United States
Optima Research - Boardman
RECRUITING

Boardman, Ohio, 44512, United States
Saguaro Dermatology
RECRUITING

Phoenix, Arizona, 85008, United States
Schweiger Dermatology, PC
RECRUITING

Hackensack, New Jersey, 07601, United States
Skin Cancer and Dermatology Institute
RECRUITING

Reno, Nevada, 89509, United States
Skin Care Research
RECRUITING

Boca Raton, Florida, 33021, United States
Southeast Research Specialist LLC
RECRUITING

Douglasville, Georgia, 30135, United States
Stryde Research-Epiphany Dermatology
RECRUITING

Southlake, Texas, 76092, United States
The Indiana Clinical Trials Center, PC
RECRUITING

Plainfield, Indiana, 46168, United States
UPMC Department of Dermatology
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States
York Dermatology Clinical and Research Centre
RECRUITING

Richmond Hill, Ontario, L4B 1L1, Canada
Ziaderm Research LLC
RECRUITING

North Miami Beach, Florida, 33126, United States

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA (HS)